Association of Age, Frailty and Strategy for Initiation of Renal Replacement Therapy: a post-hoc analysis of the STARRT-AKI trial.

析因分析 肾脏替代疗法 医学 事后 内科学 重症监护医学 临床试验
作者
Ying Wang,Ary Serpa Neto,Martin Gallagher,Ron Wald,Sean M. Bagshaw,Rinaldo Bellomo
出处
期刊:Blood Purification [Karger Publishers]
卷期号:53 (10): 781-792
标识
DOI:10.1159/000540323
摘要

Introduction: This study was designed to assess the association of age and frailty with clinical outcomes in patients with severe acute kidney injury (AKI), according to accelerated and standard renal-replacement therapy (RRT) initiation strategies in the STARRT-AKI trial. Methods: This was a secondary analysis of an international randomized trial. Older age was defined as ≥65 years. Frailty was assessed using the clinical frailty scale (CFS) score and defined as a score ≥5. The primary outcome was all-cause mortality at 90 days. Secondary outcomes included RRT dependence and RRT-free days at 90 days. We used logistic and linear regression and interaction testing to explore the impact of age and frailty on clinical outcomes. Results: Of 2,927 patients randomized in the STARRT-AKI trial, 1,616 (55.2%) were aged ≥65 years (median [interquartile range] 73.9 [69.4–78.9]). Older patients had greater comorbid cardiovascular and chronic kidney disease, were more likely to be surgical admissions and to receive vasopressors at baseline. Older patients had higher 90-day mortality (50.4% vs. 35.6%, adjusted-odds ratio (OR), 1.81 [1.53–2.13], p < 0.001). There was no significant difference in RRT dependence at 90 days between older and younger patients (8.7% vs. 7.8%, adjusted-OR, 1.21 [0.82–1.79], p = 0.325). Patients with frailty had higher mortality; but no difference in RRT dependence at 90 days. There was no significant interaction between age and CFS score in relation to mortality, RRT dependence at 90 days, and other secondary outcomes. There was no significant difference in the proportion of patients who received RRT in the standard-strategy stratified by age groups (adjusted-OR, 0.85 [0.67–1.08], p = 0.180). Conclusion: In this secondary analysis of the STARRT-AKI trial, older and frail patients had higher mortality at 90 days; however, there was no difference in RRT dependence. Mortality and RRT dependence were not modified by RRT initiation strategy in older or frail patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Zz发布了新的文献求助10
刚刚
1秒前
大个应助mtt采纳,获得10
1秒前
爆米花应助自觉水绿采纳,获得10
2秒前
2秒前
HYQ完成签到,获得积分10
3秒前
金榕发布了新的文献求助10
3秒前
深情安青应助祝一刀采纳,获得10
3秒前
3秒前
WD完成签到,获得积分10
3秒前
twisyouzi完成签到,获得积分10
5秒前
6秒前
田様应助DJY采纳,获得10
6秒前
6秒前
嗯嗯嗯发布了新的文献求助10
7秒前
核桃应助YONG采纳,获得10
8秒前
Deannn778发布了新的文献求助10
10秒前
鸣笛应助科研通管家采纳,获得30
11秒前
Hello应助科研通管家采纳,获得10
11秒前
orixero应助科研通管家采纳,获得10
11秒前
科研通AI6应助科研通管家采纳,获得10
11秒前
Jasper应助科研通管家采纳,获得10
11秒前
11秒前
雪满头应助科研通管家采纳,获得10
12秒前
所所应助科研通管家采纳,获得10
12秒前
科研通AI5应助科研通管家采纳,获得10
12秒前
柴桑青木应助科研通管家采纳,获得10
12秒前
12秒前
柴桑青木应助科研通管家采纳,获得10
12秒前
12秒前
13秒前
甜甜信封完成签到,获得积分10
14秒前
小詹完成签到,获得积分10
14秒前
拾柒完成签到,获得积分10
15秒前
嗯嗯嗯完成签到,获得积分20
15秒前
16秒前
16秒前
7U完成签到,获得积分10
17秒前
17秒前
Zz完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Voyage au bout de la révolution: de Pékin à Sochaux 700
ICDD求助cif文件 500
First Farmers: The Origins of Agricultural Societies, 2nd Edition 500
Assessment of adverse effects of Alzheimer's disease medications: Analysis of notifications to Regional Pharmacovigilance Centers in Northwest France 400
The Secrets of Successful Product Launches 300
The Rise & Fall of Classical Legal Thought 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4339344
求助须知:如何正确求助?哪些是违规求助? 3848190
关于积分的说明 12017726
捐赠科研通 3489338
什么是DOI,文献DOI怎么找? 1915027
邀请新用户注册赠送积分活动 958008
科研通“疑难数据库(出版商)”最低求助积分说明 858280